Home › Compare › EGOC vs JNJ

EGOC vs JNJ: Dividend Comparison 2026

EGOC yields 285714.29% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EGOC wins by $1.734986541242196e+31M in total portfolio value
10 years
EGOC
EGOC
● Live price
285714.29%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.734986541242196e+31M
Annual income
$17,337,928,197,276,910,000,000,000,000,000,000,000.00
Full EGOC calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — EGOC vs JNJ

📍 EGOC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEGOCJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EGOC + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
EGOC pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EGOC
Annual income on $10K today (after 15% tax)
$24,285,714.29/yr
After 10yr DRIP, annual income (after tax)
$14,737,238,967,685,373,000,000,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, EGOC beats the other by $14,737,238,967,685,373,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EGOC + JNJ for your $10,000?

EGOC: 50%JNJ: 50%
100% JNJ50/50100% EGOC
Portfolio after 10yr
$8.67493270621098e+30M
Annual income
$8,668,964,098,638,455,000,000,000,000,000,000,000.00/yr
Blended yield
99.93%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

EGOC
No analyst data
Altman Z
-345.3
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EGOC buys
0
JNJ buys
0
No recent congressional trades found for EGOC or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEGOCJNJ
Forward yield285714.29% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$1.734986541242196e+31M$20.0K ✓
Annual income after 10y$17,337,928,197,276,910,000,000,000,000,000,000,000.00 ✓$827.78
Total dividends collected$1.734908400352195e+31M$5.6K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: EGOC vs JNJ ($10,000, DRIP)

YearEGOC PortfolioEGOC Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$28,582,129$28,571,428.57$10,676$355.77+$28.57M → EGOC
2$76,351,353,429$76,320,770,551.21$11,407$389.39+$76351.34M → EGOC
3$190,619,493,207,524$190,537,797,259,355.30$12,198$426.53+$190619493.20M → EGOC
4$444,781,927,427,195,200$444,577,964,569,463,100.00$13,056$467.62+$444781927427.18M → EGOC
5$969,967,353,346,567,200,000$969,491,436,684,220,000,000.00$13,987$513.12+$969967353346567.13M → EGOC
6$1,976,961,629,315,093,000,000,000$1,975,923,764,247,012,300,000,000.00$14,998$563.56+$1976961629315092992.00M → EGOC
7$3,765,923,944,594,039,000,000,000,000$3,763,808,595,650,671,000,000,000,000.00$16,098$619.52+$3.765923944594039e+21M → EGOC
8$6,704,681,437,057,684,000,000,000,000,000$6,700,651,898,436,968,000,000,000,000,000.00$17,295$681.69+$6.704681437057683e+24M → EGOC
9$11,156,275,836,497,016,000,000,000,000,000,000$11,149,101,827,359,364,000,000,000,000,000,000.00$18,599$750.82+$1.1156275836497015e+28M → EGOC
10$17,349,865,412,421,960,000,000,000,000,000,000,000$17,337,928,197,276,910,000,000,000,000,000,000,000.00$20,022$827.78+$1.734986541242196e+31M → EGOC

EGOC vs JNJ: Complete Analysis 2026

EGOC — Stock

As of July 16, 2021, operates as a subsidiary of Shanghai Yicheng Culture Communication Co., Ltd.

Full EGOC Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this EGOC vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EGOC vs SCHDEGOC vs JEPIEGOC vs OEGOC vs KOEGOC vs MAINEGOC vs ABBVEGOC vs MRKEGOC vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.